Endometrial Receptivity Array
➩ The Endometrial receptivity genome analysis (ERA) involves assessing a woman’s endometrial receptivity status from a molecular viewpoint. This molecular tool allows us to diagnose whether the endometrium is receptive or not, by analyzing the expression of a group of genes responsible for this function. This diagnostic method patented by iGenomix focuses on women who visit the clinic for their fertility problems.
➩ With the endometrial gene expression diagnosis, problems that may affect the embryo implantation before starting the fertility treatment can be detected. As a result, corresponding measures can be taken to carry out the fertility treatment successfully. It also enables an early diagnosis of diseases originating in the endometrium.
➩ This is advised for women who do not conceive despite all tests being normal.